mutLBSgeneDB |
Gene summary for AOC3 |
Gene summary |
Basic gene Info. | Gene symbol | AOC3 |
Gene name | amine oxidase, copper containing 3 | |
Synonyms | HPAO|SSAO|VAP-1|VAP1 | |
Cytomap | UCSC genome browser: 17q21 | |
Type of gene | protein-coding | |
RefGenes | NM_001277731.1, NM_001277732.1,NM_003734.3,NR_102422.1, | |
Description | amine oxidase, copper containing 3 (vascular adhesion protein 1)copper amine oxidasemembrane primary amine oxidaseplacenta copper monamine oxidasesemicarbazide-sensitive amine oxidase | |
Modification date | 20141207 | |
dbXrefs | MIM : 603735 | |
HGNC : HGNC | ||
Ensembl : ENSG00000131471 | ||
HPRD : 04770 | ||
Vega : OTTHUMG00000180656 | ||
Protein | UniProt: Q16853 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_AOC3 | |
BioGPS: 8639 | ||
Pathway | NCI Pathway Interaction Database: AOC3 | |
KEGG: AOC3 | ||
REACTOME: AOC3 | ||
Pathway Commons: AOC3 | ||
Context | iHOP: AOC3 | |
ligand binding site mutation search in PubMed: AOC3 | ||
UCL Cancer Institute: AOC3 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0006812 | cation transport | 19764817 | GO:0007155 | cell adhesion | 9653080 | GO:0009308 | amine metabolic process | 9653080 | GO:0046677 | response to antibiotic | 19764817 | GO:0098655 | cation transmembrane transport | 19764817 |
Top |
Ligand binding site mutations for AOC3 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | K638 | R637Q | COAD | 1 | Y394 | G392C | COAD | 1 | D446 | D446Y | COAD | 1 | L365 | S364R | LUAD | 1 | I487 | I485M | LUAD | 1 | S619 | S619R | LUSC | 1 | D529 | D529V | LUSC | 1 | F389 | M391I | LUSC | 1 | S464 | S464F | SKCM | 1 | E572 | E573K | SKCM | 1 | P405 | D403G | STAD | 1 | R383 | T381M | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for AOC3 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | R383 | T381M | 0.2083448 | S619 | S619R | 0.015262062 | K638 | R637Q | -1.4665042 | E572 | E573K | -0.87264325 | S464 | S464F | -0.65124404 | I487 | I485M | -0.5067558 | F389 | M391I | -0.48126912 | P405 | D403G | -0.38261319 | L365 | S364R | -0.37541065 | D446 | D446Y | -0.34756197 | D529 | D529V | -0.34543165 | Y394 | G392C | -0.23935579 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for AOC3 from PDB |
Top |
Differential gene expression and gene-gene network for AOC3 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for AOC3 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0011853 | Diabetes Mellitus, Experimental | 3 | Biomarker |
umls:C0011881 | Diabetic Nephropathies | 1 | Biomarker |
umls:C0030524 | Paratuberculosis | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for AOC3 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Approved | DB00780 | Phenelzine | Small molecule | |
Approved | DB01275 | Hydralazine | Small molecule | |
Experimental | DB04334 | 6-hydroxydopa quinone | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of AOC3 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | CU | COPPER(2+) | 2c11 | A | D446 | CU | COPPER(2+) | 2c11 | B | D446 | CU | COPPER(2+) | 2c11 | C | D446 | CU | COPPER(2+) | 2c11 | D | D446 | CA | CALCIUM(2+) | 1pu4 | A | D529 | CA | CALCIUM(2+) | 1pu4 | B | D529 | CA | CALCIUM(2+) | 1us1 | A | D529 | CA | CALCIUM(2+) | 1us1 | B | D529 | CA | CALCIUM(2+) | 2c10 | A | D529 | CA | CALCIUM(2+) | 2c10 | B | D529 | CA | CALCIUM(2+) | 2c10 | C | D529 | CA | CALCIUM(2+) | 2c10 | D | D529 | CA | CALCIUM(2+) | 2c11 | A | D529 | CA | CALCIUM(2+) | 2c11 | B | D529 | CA | CALCIUM(2+) | 2c11 | C | D529 | CA | CALCIUM(2+) | 2c11 | D | D529 | CA | CALCIUM(2+) | 2y73 | A | D529 | CA | CALCIUM(2+) | 2y73 | B | D529 | CA | CALCIUM(2+) | 2y74 | A | D529 | CA | CALCIUM(2+) | 2y74 | B | D529 | CA | CALCIUM(2+) | 3ala | A | D529 | CA | CALCIUM(2+) | 3ala | B | D529 | CA | CALCIUM(2+) | 3ala | C | D529 | CA | CALCIUM(2+) | 3ala | D | D529 | CA | CALCIUM(2+) | 3ala | E | D529 | CA | CALCIUM(2+) | 3ala | F | D529 | CA | CALCIUM(2+) | 3ala | G | D529 | CA | CALCIUM(2+) | 4btw | A | D529 | CA | CALCIUM(2+) | 4btw | B | D529 | CA | CALCIUM(2+) | 4btx | A | D529 | CA | CALCIUM(2+) | 4btx | B | D529 | CA | CALCIUM(2+) | 4bty | A | D529 | CA | CALCIUM(2+) | 4bty | B | D529 | CA | CALCIUM(2+) | 2c10 | A | E572 | CA | CALCIUM(2+) | 2c10 | B | E572 | CA | CALCIUM(2+) | 2c10 | C | E572 | CA | CALCIUM(2+) | 2c10 | D | E572 | CA | CALCIUM(2+) | 2c11 | D | E572 | CA | CALCIUM(2+) | 2y73 | A | E572 | CA | CALCIUM(2+) | 2y74 | B | E572 | CA | CALCIUM(2+) | 1pu4 | A | E572 K638 | CA | CALCIUM(2+) | 1pu4 | B | E572 K638 | CA | CALCIUM(2+) | 1us1 | A | E572 K638 | CA | CALCIUM(2+) | 1us1 | B | E572 K638 | CA | CALCIUM(2+) | 2c11 | A | E572 K638 | CA | CALCIUM(2+) | 2c11 | B | E572 K638 | CA | CALCIUM(2+) | 2c11 | C | E572 K638 | CA | CALCIUM(2+) | 2y73 | B | E572 K638 | CA | CALCIUM(2+) | 2y74 | A | E572 K638 | CA | CALCIUM(2+) | 3ala | A | E572 K638 | CA | CALCIUM(2+) | 3ala | B | E572 K638 | CA | CALCIUM(2+) | 3ala | C | E572 K638 | CA | CALCIUM(2+) | 3ala | D | E572 K638 | CA | CALCIUM(2+) | 3ala | E | E572 K638 | CA | CALCIUM(2+) | 3ala | G | E572 K638 | CA | CALCIUM(2+) | 4btw | A | E572 K638 | CA | CALCIUM(2+) | 4btw | B | E572 K638 | CA | CALCIUM(2+) | 4btx | A | E572 K638 | CA | CALCIUM(2+) | 4btx | B | E572 K638 | CA | CALCIUM(2+) | 4bty | A | E572 K638 | CA | CALCIUM(2+) | 4bty | B | E572 K638 | JW7 | 5-(CYCLOHEXYLAMINO)-2-PHENYL-6-(1H-1,2,4- TRIAZOL-5-YL)-3(2H)-PYRIDAZINONE | 4btw | A | F389 Y394 | JW7 | 5-(CYCLOHEXYLAMINO)-2-PHENYL-6-(1H-1,2,4- TRIAZOL-5-YL)-3(2H)-PYRIDAZINONE | 4btw | B | F389 Y394 | WF8 | 5-ISOPROPYLAMINO-2-PHENYL-6-(1H-1,2,4- TRIAZOL-5-YL)-3(2H)-PYRIDAZINONE | 4btx | A | F389 Y394 | WF8 | 5-ISOPROPYLAMINO-2-PHENYL-6-(1H-1,2,4- TRIAZOL-5-YL)-3(2H)-PYRIDAZINONE | 4btx | B | F389 Y394 | JWF | 5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO]-2- (4-CHLOROPHENYL)-6-(1H-1,2,4-TRIAZOL-5-YL)- 3(2H)-PYRIDAZINONE | 4bty | A | F389 Y394 | JWF | 5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO]-2- (4-CHLOROPHENYL)-6-(1H-1,2,4-TRIAZOL-5-YL)- 3(2H)-PYRIDAZINONE | 4bty | B | F389 Y394 | IMD | IMIDAZOLIUM CATION | 2y73 | B | I487 | CA | CALCIUM(2+) | 3ala | F | K638 | IMD | IMIDAZOLIUM CATION | 2y74 | B | L365 | IMD | IMIDAZOLIUM CATION | 2y73 | A | L365 I487 | IMD | IMIDAZOLIUM CATION | 2y74 | A | L365 I487 | FMT | FORMIC ACID | 2y73 | A | P405 | FMT | FORMIC ACID | 2y73 | A | R383 S619 | IMD | IMIDAZOLIUM CATION | 2y73 | A | S464 | IMD | IMIDAZOLIUM CATION | 2y73 | B | S464 | IMD | IMIDAZOLIUM CATION | 2y74 | A | S464 | IMD | IMIDAZOLIUM CATION | 2y74 | B | S464 | IMD | IMIDAZOLIUM CATION | 2y73 | A | Y394 | IMD | IMIDAZOLIUM CATION | 2y73 | B | Y394 | IMD | IMIDAZOLIUM CATION | 2y74 | B | Y394 |
Top |
Conservation information for LBS of AOC3 |
Multiple alignments for Q16853 in multiple species |
LBS | AA sequence | # species | Species | D180 | EYLDIDQMIFN | 2 | Homo sapiens, Bos taurus | D180 | EYQDIEEMIFH | 1 | Mus musculus | D180 | EYQDIQEMIFH | 1 | Rattus norvegicus | D386 | TTRYVDGGFGM | 1 | Homo sapiens | D386 | STCYVDGSFGI | 1 | Mus musculus | D386 | STCYMDGSFGI | 1 | Rattus norvegicus | D386 | LTRYMDGCFGM | 1 | Bos taurus | D446 | RRHHSDFYSHY | 2 | Mus musculus, Rattus norvegicus | D446 | RRHHSDLYSHY | 1 | Homo sapiens | D446 | RRHHSDFISQY | 1 | Bos taurus | D476 | YDYVWDTVFHP | 1 | Homo sapiens | D476 | YDYIWDMVFHP | 1 | Mus musculus | D476 | YDYVWDMVFHS | 1 | Rattus norvegicus | D476 | YDYVWDMVFHP | 1 | Bos taurus | D529 | AHFKVDLDVAG | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | D529 | AHYKVDLDVGG | 1 | Bos taurus | D531 | FKVDLDVAGLK | 2 | Mus musculus, Rattus norvegicus | D531 | FKVDLDVAGLE | 1 | Homo sapiens | D531 | YKVDLDVGGLE | 1 | Bos taurus | D673 | TIAGKDLVAWV | 2 | Homo sapiens, Bos taurus | D673 | TIAGEDLVAWV | 2 | Mus musculus, Rattus norvegicus | E140 | KPNVSELVVGP | 2 | Mus musculus, Rattus norvegicus | E140 | QPNVSELVVGP | 1 | Homo sapiens | E140 | QPNVTELVVGP | 1 | Bos taurus | E536 | DVAGLKNWAWA | 2 | Mus musculus, Rattus norvegicus | E536 | DVAGLENWVWA | 1 | Homo sapiens | E536 | DVGGLENWVWA | 1 | Bos taurus | E572 | KLLETEEEAAF | 2 | Mus musculus, Rattus norvegicus | E572 | KLLEMEEQAAF | 1 | Homo sapiens | E572 | KQLETEEQAAF | 1 | Bos taurus | E641 | QRKEEEPSSSS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | E641 | QRKETEPSSSS | 1 | Bos taurus | E667 | DFINNETIAGK | 2 | Homo sapiens, Bos taurus | E667 | DFISNETIAGE | 2 | Mus musculus, Rattus norvegicus | F173 | RRPVLFQEYLD | 1 | Homo sapiens | F173 | RRPVLDREYQD | 1 | Mus musculus | F173 | RRPVLTREYQD | 1 | Rattus norvegicus | F173 | RRPVLLREYLD | 1 | Bos taurus | F227 | DRATWFGLYYN | 3 | Homo sapiens, Mus musculus, Bos taurus | F227 | DRATWFGIYYN | 1 | Rattus norvegicus | F389 | YVDGGFGMGKY | 1 | Homo sapiens | F389 | YVDGSFGIGKY | 1 | Mus musculus | F389 | YMDGSFGIGKY | 1 | Rattus norvegicus | F389 | YMDGCFGMGKF | 1 | Bos taurus | F526 | THSAHFKVDLD | 2 | Homo sapiens, Mus musculus | F526 | THNAHFKVDLD | 1 | Rattus norvegicus | F526 | THSAHYKVDLD | 1 | Bos taurus | F648 | SSSSVFNQNDP | 2 | Homo sapiens, Bos taurus | F648 | SSSSIFNQNDP | 1 | Mus musculus | F648 | SSSSIYNQNDP | 1 | Rattus norvegicus | F663 | VDFSDFINNET | 1 | Homo sapiens | F663 | VNFTDFISNET | 1 | Mus musculus | F663 | VDFTDFISNET | 1 | Rattus norvegicus | F663 | VDFADFINNET | 1 | Bos taurus | G30 | LVGRGGDGGEP | 1 | Homo sapiens | G30 | LAGRSGDGGGL | 1 | Mus musculus | G30 | LAGRSGDGGRL | 1 | Rattus norvegicus | G30 | IAGRGGDGGEA | 1 | Bos taurus | G671 | NETIAGKDLVA | 2 | Homo sapiens, Bos taurus | G671 | NETIAGEDLVA | 2 | Mus musculus, Rattus norvegicus | H160 | VTVERHGGPLP | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | H444 | PLRRHHSDFYS | 2 | Mus musculus, Rattus norvegicus | H444 | PLRRHHSDLYS | 1 | Homo sapiens | H444 | PLRRHHSDFIS | 1 | Bos taurus | H514 | NQVSEHTLGTV | 1 | Homo sapiens | H514 | NRVGAHTLGTV | 1 | Mus musculus | H514 | NRVAEHTLGTV | 1 | Rattus norvegicus | H514 | NQVRENTLGTV | 1 | Bos taurus | H520 | TLGTVHTHSAH | 3 | Homo sapiens, Mus musculus, Bos taurus | H520 | TLGTVHTHNAH | 1 | Rattus norvegicus | H522 | GTVHTHSAHFK | 2 | Homo sapiens, Mus musculus | H522 | GTVHTHNAHFK | 1 | Rattus norvegicus | H522 | GTVHTHSAHYK | 1 | Bos taurus | H684 | TAGFLHIPHAE | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | H762 | HGGFSHN-- | 1 | Homo sapiens | H762 | HGGFAYRDN | 1 | Mus musculus | H762 | HGGFTYK-- | 1 | Rattus norvegicus | H762 | HGGFFTN-- | 1 | Bos taurus | I349 | FSGPRIFDIRF | 3 | Mus musculus, Rattus norvegicus, Bos taurus | I349 | FSGPRIFDVRF | 1 | Homo sapiens | I487 | NGAIEVKFHAT | 3 | Mus musculus, Rattus norvegicus, Bos taurus | I487 | SGAIEIRFYAT | 1 | Homo sapiens | K106 | LQLPPKAAALA | 2 | Homo sapiens, Bos taurus | K106 | LQLPAKAAALA | 2 | Mus musculus, Rattus norvegicus | K638 | AVTQRKEEEPS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K638 | AVTQRKETEPS | 1 | Bos taurus | L177 | LFQEYLDIDQM | 1 | Homo sapiens | L177 | LDREYQDIEEM | 1 | Mus musculus | L177 | LTREYQDIQEM | 1 | Rattus norvegicus | L177 | LLREYLDIDQM | 1 | Bos taurus | L290 | LVNVVLIPDNG | 1 | Homo sapiens | L290 | LVNVVLVPNNG | 1 | Mus musculus | L290 | LVNVVLVPDNG | 1 | Rattus norvegicus | L290 | RVNVVVIPNNG | 1 | Bos taurus | L314 | GPAPPLQFYPQ | 1 | Homo sapiens | L314 | GPAPPLQFHPQ | 1 | Mus musculus | L314 | GRAPPLQFHPE | 1 | Rattus norvegicus | L314 | GPTPPLQFHPQ | 1 | Bos taurus | L365 | AYEISVQEAIA | 2 | Mus musculus, Rattus norvegicus | L365 | VYEISLQEALA | 1 | Homo sapiens | L365 | AYEISLQEAVA | 1 | Bos taurus | L447 | RHHSDFYSHYF | 2 | Mus musculus, Rattus norvegicus | L447 | RHHSDLYSHYF | 1 | Homo sapiens | L447 | RHHSDFISQYF | 1 | Bos taurus | L468 | RSVSTLLNYDY | 2 | Mus musculus, Bos taurus | L468 | RSMSTLLNYDY | 1 | Homo sapiens | L468 | RSVATLLNYDY | 1 | Rattus norvegicus | L469 | SMSTLLNYDYV | 1 | Homo sapiens | L469 | SVSTLLNYDYI | 1 | Mus musculus | L469 | SVATLLNYDYV | 1 | Rattus norvegicus | L469 | SVSTLLNYDYV | 1 | Bos taurus | L530 | HFKVDLDVAGL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L530 | HYKVDLDVGGL | 1 | Bos taurus | L535 | LDVAGLKNWAW | 2 | Mus musculus, Rattus norvegicus | L535 | LDVAGLENWVW | 1 | Homo sapiens | L535 | LDVGGLENWVW | 1 | Bos taurus | L615 | FAGKPLPQESP | 2 | Mus musculus, Rattus norvegicus | L615 | FAGEPLPQNSS | 1 | Homo sapiens | L615 | FAGRPLPQNSS | 1 | Bos taurus | L674 | IAGKDLVAWVT | 2 | Homo sapiens, Bos taurus | L674 | IAGEDLVAWVT | 2 | Mus musculus, Rattus norvegicus | N470 | MSTLLNYDYVW | 1 | Homo sapiens | N470 | VSTLLNYDYIW | 1 | Mus musculus | N470 | VATLLNYDYVW | 1 | Rattus norvegicus | N470 | VSTLLNYDYVW | 1 | Bos taurus | N537 | VAGLKNWAWAE | 2 | Mus musculus, Rattus norvegicus | N537 | VAGLENWVWAE | 1 | Homo sapiens | N537 | VGGLENWVWAE | 1 | Bos taurus | N665 | FTDFISNETIA | 2 | Mus musculus, Rattus norvegicus | N665 | FSDFINNETIA | 1 | Homo sapiens | N665 | FADFINNETIA | 1 | Bos taurus | P347 | GAFSGPRIFDI | 3 | Mus musculus, Rattus norvegicus, Bos taurus | P347 | GAFSGPRIFDV | 1 | Homo sapiens | P405 | RGVDCPYLATY | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | Q315 | PAPPLQFYPQG | 1 | Homo sapiens | Q315 | PAPPLQFHPQG | 1 | Mus musculus | Q315 | RAPPLQFHPEG | 1 | Rattus norvegicus | Q315 | PTPPLQFHPQG | 1 | Bos taurus | R383 | AAMTTRYVDGG | 1 | Homo sapiens | R383 | ASMSTCYVDGS | 1 | Mus musculus | R383 | ASMSTCYMDGS | 1 | Rattus norvegicus | R383 | AAMLTRYMDGC | 1 | Bos taurus | R463 | TVLVVRSMSTL | 1 | Homo sapiens | R463 | TVLVVRSVSTL | 1 | Mus musculus | R463 | TVLVVRSVATL | 1 | Rattus norvegicus | R463 | TVLVFRSVSTL | 1 | Bos taurus | S464 | VLVVRSMSTLL | 1 | Homo sapiens | S464 | VLVVRSVSTLL | 1 | Mus musculus | S464 | VLVVRSVATLL | 1 | Rattus norvegicus | S464 | VLVFRSVSTLL | 1 | Bos taurus | S619 | PLPQESPIEKA | 2 | Mus musculus, Rattus norvegicus | S619 | PLPQNSSMARG | 1 | Homo sapiens | S619 | PLPQNSSTERA | 1 | Bos taurus | S646 | EPSSSSVFNQN | 2 | Homo sapiens, Bos taurus | S646 | EPSSSSIFNQN | 1 | Mus musculus | S646 | EPSSSSIYNQN | 1 | Rattus norvegicus | T210 | GRNLVTMTTAP | 1 | Homo sapiens | T210 | GQNLLTMTTAP | 1 | Mus musculus | T210 | GHNLLKMTTAP | 1 | Rattus norvegicus | T210 | GGNLVTMTTAP | 1 | Bos taurus | T212 | NLVTMTTAPRG | 2 | Homo sapiens, Bos taurus | T212 | NLLTMTTAPRG | 1 | Mus musculus | T212 | NLLKMTTAPRG | 1 | Rattus norvegicus | T477 | DYVWDTVFHPS | 1 | Homo sapiens | T477 | DYIWDMVFHPN | 1 | Mus musculus | T477 | DYVWDMVFHSN | 1 | Rattus norvegicus | T477 | DYVWDMVFHPN | 1 | Bos taurus | T635 | YHLAVTQRKEE | 2 | Mus musculus, Rattus norvegicus | T635 | YQLAVTQRKEE | 1 | Homo sapiens | T635 | YQLAVTQRKET | 1 | Bos taurus | V462 | ETVLVVRSMST | 1 | Homo sapiens | V462 | GTVLVVRSVST | 1 | Mus musculus | V462 | ETVLVVRSVAT | 1 | Rattus norvegicus | V462 | ETVLVFRSVST | 1 | Bos taurus | W475 | NYDYVWDMVFH | 2 | Rattus norvegicus, Bos taurus | W475 | NYDYVWDTVFH | 1 | Homo sapiens | W475 | NYDYIWDMVFH | 1 | Mus musculus | Y176 | VLFQEYLDIDQ | 1 | Homo sapiens | Y176 | VLDREYQDIEE | 1 | Mus musculus | Y176 | VLTREYQDIQE | 1 | Rattus norvegicus | Y176 | VLLREYLDIDQ | 1 | Bos taurus | Y384 | AMTTRYVDGGF | 1 | Homo sapiens | Y384 | SMSTCYVDGSF | 1 | Mus musculus | Y384 | SMSTCYMDGSF | 1 | Rattus norvegicus | Y384 | AMLTRYMDGCF | 1 | Bos taurus | Y394 | FGMGKYTTPLT | 1 | Homo sapiens | Y394 | FGIGKYSTPLI | 1 | Mus musculus | Y394 | FGIGKYSTPLT | 1 | Rattus norvegicus | Y394 | FGMGKFATPLT | 1 | Bos taurus | Y406 | GVDCPYLATYV | 4 | Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus | Y448 | HHSDFYSHYFG | 2 | Mus musculus, Rattus norvegicus | Y448 | HHSDLYSHYFG | 1 | Homo sapiens | Y448 | HHSDFISQYFG | 1 | Bos taurus | Y471 | STLLNYDYVWD | 2 | Homo sapiens, Bos taurus | Y471 | STLLNYDYIWD | 1 | Mus musculus | Y471 | ATLLNYDYVWD | 1 | Rattus norvegicus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |